All animal experiments were performed under UK Home Office Licence authority. Braf+/LSL−V600E, Kras+/LSL−G12D and CCAGCreERTM mice were backcrossed onto the C57BL/6J strain and genotyped as reported (Kamata et al., 2017 (link), 2020 (link)). Male and female animals >8 weeks of age were used for experimental procedures. Nasal delivery of Ad5-CMV-Cre or Ad5-mSPC-Cre was performed as described (Kamata et al., 2017 (link), 2020 (link)). Atorvastatin (10 mg/kg, Generon) was orally administered once daily for the indicated periods. Lung tissues were processed for Haematoxylin and Eosin (H&E) staining and immunohistochemistry (IHC) as described (Kamata et al., 2020 (link)).
Free full text: Click here